ACADIA Pharmaceuticals Inc (ACAD)

45.75 -1.15  -2.45% NASDAQ Jun 4, 20:00 Delayed 2m USD

ACADIA Pharmaceuticals Total Liabilities (Quarterly):

109.07M for March 31, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Total Liabilities (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Total Liabilities (Quarterly) Data

View and export this data going back to 2003. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2020 109.07M
Dec. 31, 2019 84.05M
Sept. 30, 2019 76.30M
June 30, 2019 71.97M
March 31, 2019 82.75M
Dec. 31, 2018 61.12M
Sept. 30, 2018 43.02M
June 30, 2018 50.24M
March 31, 2018 46.87M
Dec. 31, 2017 49.22M
Sept. 30, 2017 36.39M
June 30, 2017 41.18M
March 31, 2017 45.49M
Dec. 31, 2016 42.74M
Sept. 30, 2016 39.33M
June 30, 2016 29.22M
March 31, 2016 21.34M
Dec. 31, 2015 22.13M
Sept. 30, 2015 17.97M
June 30, 2015 19.72M
March 31, 2015 16.87M
Dec. 31, 2014 15.97M
Sept. 30, 2014 11.27M
June 30, 2014 9.357M
March 31, 2014 8.046M
   
Dec. 31, 2013 6.987M
Sept. 30, 2013 18.53M
June 30, 2013 25.43M
March 31, 2013 23.35M
Dec. 31, 2012 23.61M
Sept. 30, 2012 6.086M
June 30, 2012 9.166M
March 31, 2012 8.934M
Dec. 31, 2011 8.752M
Sept. 30, 2011 8.878M
June 30, 2011 8.488M
March 31, 2011 8.779M
Dec. 31, 2010 8.706M
Sept. 30, 2010 35.92M
June 30, 2010 36.01M
March 31, 2010 36.18M
Dec. 31, 2009 37.57M
Sept. 30, 2009 39.51M
June 30, 2009 43.65M
March 31, 2009 11.98M
Dec. 31, 2008 11.68M
Sept. 30, 2008 11.96M
June 30, 2008 14.88M
March 31, 2008 14.66M
Dec. 31, 2007 20.65M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Benchmarks

Benchmarks
Kodiak Sciences Inc 115.36M
Karyopharm Therapeutics Inc 249.99M
Alnylam Pharmaceuticals Inc 929.90M

Total Liabilities (Quarterly) Range, Past 5 Years

Minimum 17.97M Sep 2015
Maximum 109.07M Mar 2020
Average 49.51M
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.